Fast In-House Next-Generation Sequencing in the Diagnosis of Metastatic Non-small Cell Lung Cancer: A Hospital Budget Impact Analysis
**Background:** Targeted therapy for cancer is becoming more frequent as the understanding of the molecular pathogenesis increases. Molecular testing must be done to use targeted therapy. Unfortunately, the testing turnaround time can delay the initiation of targeted therapy. **Objective:** To inve...
Saved in:
Main Authors: | Ubong Silas, Maximilian Blüher, Antonia Bosworth Smith, Rhodri Saunders |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
2023-06-01
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | https://doi.org/10.36469/001c.77686 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expanding Viral Diversity in Rice Fields by Next-Generation Sequencing
by: Wang Haoran, et al.
Published: (2025-01-01) -
Sternal-Wound Infections following Coronary Artery Bypass Graft: Could Implementing Value-Based Purchasing be Beneficial?
by: Dominique Brandt, et al.
Published: (2020-08-01) -
Developing transcriptomic biomarkers for TAVO412 utilizing next generation sequencing analyses of preclinical tumor models
by: Ying Jin, et al.
Published: (2025-02-01) -
Diagnostic Accuracy of Next Generation Sequencing Panel using Circulating Tumor DNA in Patients with Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Mariana M. Sebastião, et al.
Published: (2020-09-01) -
One-step diagnosis of infection and lung cancer using metagenomic sequencing
by: Shaoqiang Li, et al.
Published: (2025-02-01)